IL9 and neoplasm: Another cytokine that has been associated with an antitumor response is IL-9, which favors the activation of cytotoxic T lymphocytes by recruiting dendritic cells to tumor tissues for the presentation of these antigens and the subsequent elimination of malignant cells [65,66].